Antidote For Xarelto, Eliquis Bleeding Events Approved For Large-Scale Production
The FDA has approved Andexxa, a reversal agent for Xarelto and Eliquis, for large-scale production in the face of growing bleeding injury reports.…
The FDA has approved Andexxa, a reversal agent for Xarelto and Eliquis, for large-scale production in the face of growing bleeding injury reports.…
The release of the highly anticipated Xarelto reversal agent, AndexXa, will be limited to only 40 to 50 hospitals until at least next year, due to concerns the FDA has over the manufacturing process, Portolo Pharmaceuticals CEO told investors.…
A new reversal agent has been approved for Xarelto and Eliquis but will only continue to be approved if postmarketing studies find no problems.…